Effect of Chest Physiotherapy on Clinical Outcome of Infants With Bronchiolitis
Launched by HAWLER MEDICAL UNIVERSITY · Mar 3, 2025
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at how chest physiotherapy, which is a type of physical treatment to help clear mucus from the lungs, can affect infants under 12 months old who have bronchiolitis, a common respiratory illness. The study aims to find out if this therapy can improve the health of these infants and if teaching mothers about chest physiotherapy helps them provide better care at home. Researchers will compare two groups: one group will receive standard hospital care, while the other group will receive the same care plus chest physiotherapy that mothers will learn to perform.
To participate in this trial, mothers need to have an infant diagnosed with bronchiolitis and a specific lung sound called crackles when a doctor listens to their chest. However, infants who have certain medical conditions or have been admitted to the Intensive Care Unit will not be eligible. If you join the study, you can expect to be followed for three days, and your involvement will contribute to understanding how this treatment can help young children with respiratory issues.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Mothers of infants diagnosed with bronchiolitis. 2. Presence of crackle on auscultation.
- Exclusion Criteria:
- • 1. Children with contraindication of chest physiotherapy (ex. Fracture, recent surgery)
- • 2. Children who intubated and admitted to Intensive Care Unit (ICU).
About Hawler Medical University
Hawler Medical University is a prominent academic institution dedicated to advancing medical education, research, and clinical practice in the Kurdistan Region of Iraq. As a clinical trial sponsor, the university prioritizes the integration of innovative research methodologies to enhance healthcare outcomes. Committed to ethical standards and scientific rigor, Hawler Medical University collaborates with a diverse network of healthcare professionals and researchers to conduct impactful clinical trials that address pressing health challenges. Through its initiatives, the university aims to contribute to the global body of medical knowledge while fostering a culture of inquiry and excellence in the region.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Erbil, Kurdistan, Iraq
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported